Key Takeaway
What to expect on liraglutide 1.8mg. Covers appetite changes, side effects, early weight loss acceleration, and how this dose bridges the gap between introductory and therapeutic levels.
Liraglutide 1.8mg is the third step in the five-step titration and a important dose level where the medication's appetite-suppressing effect becomes clearly noticeable for most patients. At 1.8mg, you can expect meaningful appetite reduction, a real decrease in food noise and cravings, and the beginning of genuine weight loss. This dose is also the maximum for the diabetes indication (Victoza), so it has an extensive safety record spanning years of clinical use.
1.8mg: Where Treatment Gets Real
If 0.6mg was the on-ramp and 1.2mg was first gear, 1.8mg is where you start to feel the engine. At 60 percent of the target dose, most patients notice a clear shift in their relationship with food:
- Meals genuinely satisfy with smaller portions
- The gap between meals feels comfortable rather than painful
- Cravings lose their urgency. You may still want certain foods, but the compulsive pull weakens.
- Food noise (constant mental preoccupation with eating) begins to quiet
This is the dose where many patients first think, "Okay, this is actually working." If you felt nothing at 0.6mg and very little at 1.2mg, 1.8mg is likely to change that. liraglutide 1.2mg what to expect
The First Week at 1.8mg
- Day 1: First injection at the new dose. The 50 percent increase from 1.2mg is the largest proportional step remaining in the titration. Appetite suppression noticeably deepens within hours for some patients.
- Days 2 to 3: Steady-state levels at 1.8mg are reached. Nausea may return for a brief window, affecting approximately 20 to 30 percent of patients. For most, it's milder than any nausea experienced at earlier dose increases.
- Days 3 to 5: The appetite effect is in full gear. Meals feel smaller and more satisfying. Some patients report that the thought of eating large portions becomes unappealing.
- Days 6 to 7: Adaptation is complete for most patients. The 1.8mg effect feels stable and predictable. If GI symptoms persist, consider an extra week before moving to 2.4mg.
Weight Loss at 1.8mg
This is where the weight loss curve begins to steepen:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- During the 1.8mg week: 1 to 3 pounds lost
- Cumulative after 3 weeks of treatment: 3 to 7 pounds total
- Long-term at 1.8mg (diabetes data): Approximately 4 to 5 percent of body weight over 6 months
For patients using 1.8mg as the maximum Victoza dose for diabetes, this level of weight loss is a welcome secondary benefit. For weight management patients titrating toward 3.0mg, the 1.8mg results preview what the full dose will deliver at greater intensity. liraglutide 1.8mg weight loss average
Blood Sugar Effects at 1.8mg
At the maximum Victoza dose, liraglutide's glucose-lowering effect is fully expressed:
- A1C reduction of approximately 1.0 to 1.5 percentage points in patients with type 2 diabetes
- Improved fasting plasma glucose
- Reduced post-meal glucose spikes
- Enhanced insulin sensitivity
For patients without diabetes, these effects manifest as more stable energy levels throughout the day. The blood sugar roller coaster that drives mid-afternoon cravings becomes smoother.
Practical Life at 1.8mg
Compared to the first two weeks of treatment, several practical shifts emerge at 1.8mg:
- Meal planning becomes easier: With clearer appetite control, you can plan meals around nutrition rather than cravings. Protein, vegetables, and whole foods become the natural choices when you're eating because you should rather than because you're driven to.
- Social eating adjusts: At restaurants, you may find you can't finish half your usual order. Consider appetizer portions or sharing entrees.
- Pen usage increases: At 1.8mg daily, each Saxenda pen (18mg total) lasts about 10 days. Make sure your supply is adequate. Contact provider for current pricing
- Hydration matters more: With less food intake, you get less water from food. Consciously drinking 64 to 80 ounces daily helps prevent constipation and headaches.
Medical References
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
- Is 1.8mg enough for weight loss, or do I need to continue to 3.0mg?
- For most weight management patients, 1.8mg isn't the final dose. The SCALE trial[1] showed that 3.0mg produces roughly twice the weight loss of 1.8mg over time. But some patients achieve satisfactory results at 1.8mg and their prescriber may allow them to stay there. liraglutide 1.8mg how long to stay on
- I am having more nausea at 1.8mg than at previous doses. Is that normal?
- Yes. The 1.8mg dose represents a meaningful jump in GLP-1 receptor activation. Nausea at this level is more common than at lower doses but is typically brief (2 to 4 days). If it persists beyond one week, discuss options with your prescriber. liraglutide 1.8mg side effects
- Can I stay at 1.8mg if I am using Saxenda?
- Your prescriber may allow it, but the FDA-approved target dose for Saxenda is 3.0mg. Staying at 1.8mg means accepting a lower level of weight loss effectiveness. Some prescribers support this if you're losing weight and the side effects at higher doses are problematic.
- How does liraglutide 1.8mg compare to semaglutide 0.5mg?
- Semaglutide 0.5mg (an early titration dose for Ozempic or Wegovy) produces comparable or slightly stronger appetite suppression than liraglutide 1.8mg, despite being a lower absolute dose. Semaglutide is a more potent GLP-1 agonist.